Skip to main content
Top
Published in: AIDS and Behavior 9/2014

01-09-2014 | Original Paper

Effects of Messaging About Multiple Biomedical and Behavioral HIV Prevention Methods on Intentions to use Among US MSM: Results of an Experimental Messaging Study

Authors: Brian Mustanski, Daniel T. Ryan, Travis Sanchez, Craig Sineath, Kathryn Macapagal, Patrick S. Sullivan

Published in: AIDS and Behavior | Issue 9/2014

Login to get access

Abstract

Combining multiple biomedical and behavioral HIV prevention approaches is a priority for at-risk populations such as men who have sex with men (MSM), and it is essential to understand how receiving messages about multiple approaches impacts attitudes and intentions for their use. We examined whether receiving combinations of different HIV prevention messages produced differences in perceived benefits and costs of condom use, and in intentions to use condoms and biomedical prevention approaches. MSM (N = 803) were recruited online and were randomly assigned to view informational messages about one, two, or four of the following prevention options: pre-exposure prophylaxis (PrEP), non-occupational post-exposure prophylaxis (nPEP), rectal microbicides, and condoms. The number of HIV prevention messages did not produce differential attitudes and intentions regarding condoms, nor did it produce changes in attitudes towards unprotected sex. Receiving multiple messages was associated with greater intentions to use PrEP and nPEP, but not rectal microbicides.
Appendix
Available only for authorised users
Literature
1.
go back to reference US Food and Drug Administration. FDA approves first drug for reducing the risk of sexually acquired HIV infection: US Department of Health and Human Services. 2012. US Food and Drug Administration. FDA approves first drug for reducing the risk of sexually acquired HIV infection: US Department of Health and Human Services. 2012.
4.
go back to reference CDC. Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States. MMWR. 2005;54:1–20. CDC. Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States. MMWR. 2005;54:1–20.
5.
go back to reference Abdool Karim Q, Abdool Karim SS, Frohlich JA, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329:1168–74.PubMedCentralPubMedCrossRef Abdool Karim Q, Abdool Karim SS, Frohlich JA, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329:1168–74.PubMedCentralPubMedCrossRef
8.
go back to reference Fallon SJ, Forrest DW. Unexamined challenges to applying the treatment as prevention model among men who have sex with men in the United States: a community public health perspective. AIDS Behav. 2012;16:1739–42.PubMedCrossRef Fallon SJ, Forrest DW. Unexamined challenges to applying the treatment as prevention model among men who have sex with men in the United States: a community public health perspective. AIDS Behav. 2012;16:1739–42.PubMedCrossRef
9.
go back to reference Prestage G, Mao L, Kippax S, et al. Use of viral load to negotiate condom use among gay men in Sydney, Australia. AIDS Behav. 2009;13:645–51.PubMedCrossRef Prestage G, Mao L, Kippax S, et al. Use of viral load to negotiate condom use among gay men in Sydney, Australia. AIDS Behav. 2009;13:645–51.PubMedCrossRef
10.
11.
12.
go back to reference Smith DK, Grohskopf LA, Black RJ, et al. Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States: recommendations from the US Department of Health and Human Services. MMWR Recomm Rep. 2005;54:1–20.PubMed Smith DK, Grohskopf LA, Black RJ, et al. Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States: recommendations from the US Department of Health and Human Services. MMWR Recomm Rep. 2005;54:1–20.PubMed
13.
go back to reference Landovitz RJ. Occupational and nonoccupational postexposure prophylaxis for HIV in 2009. Topics in HIV medicine: a publication of the International AIDS Society, USA. 2009;17:104–8. Landovitz RJ. Occupational and nonoccupational postexposure prophylaxis for HIV in 2009. Topics in HIV medicine: a publication of the International AIDS Society, USA. 2009;17:104–8.
14.
go back to reference Eaton LA, Kalichman S. Risk compensation in HIV prevention: implications for vaccines, microbicides, and other biomedical HIV prevention technologies. Curr HIV/AIDS Rep. 2007;4:165–72.PubMedCentralPubMedCrossRef Eaton LA, Kalichman S. Risk compensation in HIV prevention: implications for vaccines, microbicides, and other biomedical HIV prevention technologies. Curr HIV/AIDS Rep. 2007;4:165–72.PubMedCentralPubMedCrossRef
15.
go back to reference Zajonc RB. Mere exposure: a gateway to the subliminal. Curr Dir Psychol Sci. 2001;10:224–8.CrossRef Zajonc RB. Mere exposure: a gateway to the subliminal. Curr Dir Psychol Sci. 2001;10:224–8.CrossRef
16.
17.
go back to reference Golub SA, Kowalczyk W, Weinberger CL, Parson JT. Preexposure prophylaxis and predicted condom use among high-risk men who have sex with men. J Acquir Immune Defic Syndr. 2010;54:548–55.PubMedCentralPubMedCrossRef Golub SA, Kowalczyk W, Weinberger CL, Parson JT. Preexposure prophylaxis and predicted condom use among high-risk men who have sex with men. J Acquir Immune Defic Syndr. 2010;54:548–55.PubMedCentralPubMedCrossRef
18.
go back to reference Holt M, Murphy DA, Callander D, et al. Willingness to use HIV pre-exposure prophylaxis and the likelihood of decreased condom use are both associated with unprotected anal intercourse and the perceived likelihood of becoming HIV positive among Australian gay and bisexual men. Sex Transm Infect. 2012;88:258–63.PubMedCrossRef Holt M, Murphy DA, Callander D, et al. Willingness to use HIV pre-exposure prophylaxis and the likelihood of decreased condom use are both associated with unprotected anal intercourse and the perceived likelihood of becoming HIV positive among Australian gay and bisexual men. Sex Transm Infect. 2012;88:258–63.PubMedCrossRef
19.
go back to reference Martin JN, Roland ME, Neilands TB, et al. Use of postexposure prophylaxis against HIV infection following sexual exposure does not lead to increases in high-risk behavior. AIDS. 2004;18:787–92.PubMedCrossRef Martin JN, Roland ME, Neilands TB, et al. Use of postexposure prophylaxis against HIV infection following sexual exposure does not lead to increases in high-risk behavior. AIDS. 2004;18:787–92.PubMedCrossRef
20.
go back to reference Korner H, Hendry O, Kippax S. Safe sex after post-exposure prophylaxis for HIV: intentions, challenges and ambivalences in narratives of gay men. AIDS Care. 2006;18:879–87.PubMedCrossRef Korner H, Hendry O, Kippax S. Safe sex after post-exposure prophylaxis for HIV: intentions, challenges and ambivalences in narratives of gay men. AIDS Care. 2006;18:879–87.PubMedCrossRef
21.
go back to reference Schechter M, do Lage RF, Mendelsohn AB, Moreira RI, Moulton LH, Harrison LH. Behavioral impact, acceptability, and HIV incidence among homosexual men with access to postexposure chemoprophylaxis for HIV. JAIDS. 2004;35:519–25.PubMed Schechter M, do Lage RF, Mendelsohn AB, Moreira RI, Moulton LH, Harrison LH. Behavioral impact, acceptability, and HIV incidence among homosexual men with access to postexposure chemoprophylaxis for HIV. JAIDS. 2004;35:519–25.PubMed
22.
go back to reference Bartholow BN, Buchbinder S, Celum C, et al. HIV sexual risk behavior over 36 months of follow-up in the world’s first HIV vaccine efficacy trial. J Acquir Immune Defic Syndr. 2005;39:90–101.PubMedCrossRef Bartholow BN, Buchbinder S, Celum C, et al. HIV sexual risk behavior over 36 months of follow-up in the world’s first HIV vaccine efficacy trial. J Acquir Immune Defic Syndr. 2005;39:90–101.PubMedCrossRef
23.
go back to reference Liu AY, Vittinghoff E, Chillag K, et al. Sexual risk behavior among HIV-uninfected men who have sex with men participating in a tenofovir preexposure prophylaxis randomized trial in the United States. J Acquir Immune Defic Syndr. 2013;64:87–94.PubMedCrossRef Liu AY, Vittinghoff E, Chillag K, et al. Sexual risk behavior among HIV-uninfected men who have sex with men participating in a tenofovir preexposure prophylaxis randomized trial in the United States. J Acquir Immune Defic Syndr. 2013;64:87–94.PubMedCrossRef
25.
go back to reference Miller LC, Murphy ST, Clark LF, Hamburger M, Moore J. Hierarchical messages for introducing multiple HIV prevention options: promise and pitfalls. AIDS Educ Prev. 2004;16:509–25.PubMedCrossRef Miller LC, Murphy ST, Clark LF, Hamburger M, Moore J. Hierarchical messages for introducing multiple HIV prevention options: promise and pitfalls. AIDS Educ Prev. 2004;16:509–25.PubMedCrossRef
26.
go back to reference Farr G, Castro LAA, Disantostefano R, Classen EBJ, Olguin F. Use of spermicide and impact of prophylactic condom use among sex workers in Santa Fe de Bogota, Colombia. Sex Transm Dis. 1996;23:206–12.PubMedCrossRef Farr G, Castro LAA, Disantostefano R, Classen EBJ, Olguin F. Use of spermicide and impact of prophylactic condom use among sex workers in Santa Fe de Bogota, Colombia. Sex Transm Dis. 1996;23:206–12.PubMedCrossRef
27.
go back to reference Fontanet AL, Saba J, Chandelying V, et al. Protection against sexually transmitted diseases by granting sex workers in Thailand the choice of using the male or female condom: results from a randomized controlled trial. Aids. 1998;12:1851–9.PubMedCrossRef Fontanet AL, Saba J, Chandelying V, et al. Protection against sexually transmitted diseases by granting sex workers in Thailand the choice of using the male or female condom: results from a randomized controlled trial. Aids. 1998;12:1851–9.PubMedCrossRef
28.
go back to reference Janis IL, Mann L. A conflict theory approach to attitude and decision making. In: Greenwald AG, Brock TC, Ostrom TM, editors. Psychological foundations of attitudes. New York: Academic Press; 1968. Janis IL, Mann L. A conflict theory approach to attitude and decision making. In: Greenwald AG, Brock TC, Ostrom TM, editors. Psychological foundations of attitudes. New York: Academic Press; 1968.
29.
go back to reference Janis IL, Mann L. Decision making: a psychological analysis of conflict, choice, and commitment. New York: The Free Press; 1977. Janis IL, Mann L. Decision making: a psychological analysis of conflict, choice, and commitment. New York: The Free Press; 1977.
30.
go back to reference Prochaska JO, Redding CA, Harlow LL, Rossi JS, Velicer WF. The transtheoretical model of change and HIV prevention: a review. Health Educ Behav. 1994;21:471–86.CrossRef Prochaska JO, Redding CA, Harlow LL, Rossi JS, Velicer WF. The transtheoretical model of change and HIV prevention: a review. Health Educ Behav. 1994;21:471–86.CrossRef
31.
go back to reference Prochaska JO, Velicer WF, Rossi JS, et al. Stages of change and decisional balance for 12 problem behaviors. Health Psychol. 1994;13:39–46.PubMedCrossRef Prochaska JO, Velicer WF, Rossi JS, et al. Stages of change and decisional balance for 12 problem behaviors. Health Psychol. 1994;13:39–46.PubMedCrossRef
34.
go back to reference Sullivan PS, Peterson J, Rosenberg E, Kelley CF, Cooper H, Vaughan A. Understanding racial HIV/STI disparities in black and white men who have sex with men: a multilevel approach. PLoS ONE. 2014;9(3):e90514.PubMedCentralPubMedCrossRef Sullivan PS, Peterson J, Rosenberg E, Kelley CF, Cooper H, Vaughan A. Understanding racial HIV/STI disparities in black and white men who have sex with men: a multilevel approach. PLoS ONE. 2014;9(3):e90514.PubMedCentralPubMedCrossRef
35.
go back to reference Parsons JT, Halkitis PN, Borkowski T, Bimbi D. Perceptions of the benefits and costs associated with condom use and unprotected sex among late adolescent college students. J Adolesc. 2000;23:377–91.PubMedCrossRef Parsons JT, Halkitis PN, Borkowski T, Bimbi D. Perceptions of the benefits and costs associated with condom use and unprotected sex among late adolescent college students. J Adolesc. 2000;23:377–91.PubMedCrossRef
36.
go back to reference Cortina JM. What is coefficient alpha? An examination of theory and applications. J Appl Psychol. 1993;78:98–104.CrossRef Cortina JM. What is coefficient alpha? An examination of theory and applications. J Appl Psychol. 1993;78:98–104.CrossRef
37.
go back to reference Krakower DS, Mimiaga MJ, Rosenberger JG, et al. Limited awareness and low immediate uptake of pre-exposure prophylaxis among men who have sex with men using an internet social networking site. PLoS ONE. 2012;7:e33119.PubMedCentralPubMedCrossRef Krakower DS, Mimiaga MJ, Rosenberger JG, et al. Limited awareness and low immediate uptake of pre-exposure prophylaxis among men who have sex with men using an internet social networking site. PLoS ONE. 2012;7:e33119.PubMedCentralPubMedCrossRef
38.
39.
go back to reference Thigpen MC, Kebaabetswe PM, Paxton LA, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012;367:423–34.PubMedCrossRef Thigpen MC, Kebaabetswe PM, Paxton LA, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012;367:423–34.PubMedCrossRef
Metadata
Title
Effects of Messaging About Multiple Biomedical and Behavioral HIV Prevention Methods on Intentions to use Among US MSM: Results of an Experimental Messaging Study
Authors
Brian Mustanski
Daniel T. Ryan
Travis Sanchez
Craig Sineath
Kathryn Macapagal
Patrick S. Sullivan
Publication date
01-09-2014
Publisher
Springer US
Published in
AIDS and Behavior / Issue 9/2014
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-014-0811-2

Other articles of this Issue 9/2014

AIDS and Behavior 9/2014 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.